Fermenta Biotech Limited (BOM:506414)
274.60
-0.40 (-0.15%)
At close: Apr 17, 2025
Fermenta Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Net Income | - | -230.6 | -510.75 | 154.47 | 455.07 | 595.26 | Upgrade
|
Depreciation & Amortization | - | 244.55 | 277.83 | 248.84 | 196.52 | 143.34 | Upgrade
|
Other Amortization | - | 2.65 | 4.64 | 6.78 | 6.57 | 6.66 | Upgrade
|
Loss (Gain) From Sale of Assets | - | 381.26 | 447.58 | 0.27 | 1.6 | 1.55 | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | - | - | - | 3.91 | Upgrade
|
Stock-Based Compensation | - | 1.91 | -10.19 | 26.97 | 59.21 | 55.47 | Upgrade
|
Provision & Write-off of Bad Debts | - | 8.56 | 53 | 14.47 | 20.99 | 13.38 | Upgrade
|
Other Operating Activities | - | 318.1 | 449.45 | 156.41 | 37.24 | -184.72 | Upgrade
|
Change in Accounts Receivable | - | -339.48 | 353.07 | -170.17 | 64.61 | 0.97 | Upgrade
|
Change in Inventory | - | 427.56 | 99.31 | 27.94 | -191.66 | -409.17 | Upgrade
|
Change in Accounts Payable | - | 243.19 | -152.71 | 31.3 | -75.25 | 155.47 | Upgrade
|
Change in Other Net Operating Assets | - | -4.23 | 149.85 | -62.85 | 51.09 | -37.53 | Upgrade
|
Operating Cash Flow | - | 1,053 | 1,161 | 434.41 | 625.97 | 344.6 | Upgrade
|
Operating Cash Flow Growth | - | -9.27% | 167.28% | -30.60% | 81.65% | -61.86% | Upgrade
|
Capital Expenditures | - | -192.07 | -404.89 | -371.28 | -552.71 | -684.69 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.65 | 0.46 | 0.91 | 0.13 | - | Upgrade
|
Cash Acquisitions | - | - | - | - | -94.39 | - | Upgrade
|
Investment in Securities | - | 40.34 | -163.9 | 38.81 | 18.03 | -18.04 | Upgrade
|
Other Investing Activities | - | -3.9 | 14.25 | 71.19 | 213.44 | 266.14 | Upgrade
|
Investing Cash Flow | - | -154.97 | -554.09 | -260.38 | -415.5 | -436.59 | Upgrade
|
Short-Term Debt Issued | - | - | 22.91 | 5.97 | 35.85 | 168.9 | Upgrade
|
Long-Term Debt Issued | - | 30.54 | 363.08 | 243.05 | 291.65 | 308.6 | Upgrade
|
Total Debt Issued | - | 30.54 | 386 | 249.02 | 327.5 | 477.49 | Upgrade
|
Short-Term Debt Repaid | - | -218.15 | - | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -518.17 | -552.37 | -225.96 | -163.59 | -674.22 | Upgrade
|
Total Debt Repaid | - | -736.32 | -552.37 | -225.96 | -163.59 | -674.22 | Upgrade
|
Net Debt Issued (Repaid) | - | -705.79 | -166.37 | 23.06 | 163.91 | -196.72 | Upgrade
|
Common Dividends Paid | - | -36.09 | -42 | -72.12 | - | -59.72 | Upgrade
|
Other Financing Activities | - | -166.64 | -205.43 | -166.73 | -175.34 | -218.04 | Upgrade
|
Financing Cash Flow | - | -908.52 | -413.8 | -215.78 | -11.43 | -474.47 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | 0.49 | - | 6.12 | - | Upgrade
|
Net Cash Flow | - | -10.03 | 193.69 | -41.75 | 205.16 | -566.47 | Upgrade
|
Free Cash Flow | - | 861.39 | 756.19 | 63.13 | 73.26 | -340.1 | Upgrade
|
Free Cash Flow Growth | - | 13.91% | 1097.83% | -13.83% | - | - | Upgrade
|
Free Cash Flow Margin | - | 25.66% | 21.61% | 1.58% | 1.94% | -11.61% | Upgrade
|
Free Cash Flow Per Share | - | 29.83 | 26.20 | 2.18 | 2.53 | -11.73 | Upgrade
|
Cash Interest Paid | - | 166.64 | 205.43 | 166.73 | 175.34 | 205.59 | Upgrade
|
Cash Income Tax Paid | - | -10.18 | -32.08 | 93.08 | 135.22 | 151.89 | Upgrade
|
Levered Free Cash Flow | - | 158.24 | 528.43 | -163.2 | 110.82 | -973.75 | Upgrade
|
Unlevered Free Cash Flow | - | 264.78 | 658.32 | -61.52 | 208.76 | -860.98 | Upgrade
|
Change in Net Working Capital | - | -188.27 | -855.47 | 197.68 | -114.71 | 699.45 | Upgrade
|
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.